Skip to content

Offering Costs at other companies

Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$180K
Cal-Maine Foods logo
Cal-Maine FoodsCALM
$1.7M
MidCap Financial Investment Corporation logo
MidCap Financial Investment CorporationMFIC
$300K
Golub Capital logo
Golub CapitalGBDC
$288.04M
Immunome logo
ImmunomeIMNM
$364K-96.5%
Redwire logo
RedwireRDW
$437.25K

Other financials

Income statement

See full
Revenue$19.1M+109%
Gross profit$4.5M+57.6%
Operating income-$2.5M-82.0%
Net income-$4.1M-14.6%
EPS (diluted)-$0.07-75.0%

Balance sheet

See full
Cash & equivalents$55.2M+753%
Total debt$11.4M-20.7%
Total equity$89.1M+467%
Total assets$144.3M+77.2%

Cash flow

See full
Operating cash flow-$6.8M-110%
CapEx$899.5K+114%
Free cash flow-$7.7M-110%

Valuation

See full
Market cap$816.26M+548%
Enterprise value$772.4M+480%
P/S13×+9.3×

Profitability

See full
Gross margin26.8%-1.7pp
Operating margin-29.5%+6.9pp
Net margin-37.4%+11.5pp
FCF margin-16.4%-2.1pp

Returns & leverage

See full
Return on equity-44.8%+2.1pp
Debt / equity0.1×-0.8×
Current ratio3.9×+1.6×

Where this comes from

Reported directly by Lightpath Technologies in its filing.

Tagged under the XBRL concept lpth:OfferingCosts.

The official record: Lightpath Technologies’s 10-K, filed September 26, 2025, on SEC EDGAR. View the filing →

Ask your AI about Lightpath Technologies's offering costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lightpath Technologies's offering costs?
Lightpath Technologies (LPTH) reported offering costs of $550K in Q2 2025.
What does offering costs mean?
Direct costs incurred in connection with the issuance of equity or debt securities, such as underwriting fees, legal expenses, and registration costs. Monitoring these costs is important for understanding the efficiency of the company's capital-raising processes.